cognitive cybersecurity intelligence

News and Analysis

Search

Biomanufacturing Gains as Lab Leasing Lags

Biomanufacturing Gains as Lab Leasing Lags

U.S. life sciences real estate faces turbulence in 2025 due to business uncertainty and a drop in demand. However, with 15 major pharmaceutical firms announcing over $270 billion in U.S. biomanufacturing and R&D investments over the next five to 10 years, a boom may be on the horizon. Despite a reset in lab production, diminishing inventory and persistent economic uncertainties, innovative strategies are expected to emerge for lab and biomanufacturing spaces to enhance flexibility and efficiency.

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts